Table 2 Univariate and multivariate regression analysis for evaluating risk factors for IgAV recurrence in children
From: Association between common laboratory indices and IgAV recurrence in children
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
Duration of illness | 1.169 (1.074, 1.272) | 0.000 | 1.198 (1.092, 1.315) | 0.000 |
Duration of treatment | 1.105 (0.978, 1.249) | 0.110 | 1.142 (0.999, 1.306) | 0.052 |
Presence of respiratory tract infection | 0.521 (0.224, 1.215) | 0.521 | 0.308 (0.113, 0.839) | 0.210 |
Joint involvement | 1.643 (0.775, 3.484) | 0.195 | 2.596 (1.097, 6.147) | 0.030 |
Use of CS | 1.466(0.624,3.446) | 0.391 | Â | Â |
WBC | 0.949 (0.863, 1.042) | 0.949 | Â | Â |
NEU | 0.957 (0.867, 1.057) | 0.385 | Â | Â |
LYM | 0.868 (0.632, 1.192) | 0.382 | Â | Â |
PLT | 1.000 (0.997, 1.004) | 0.814 | Â | Â |
MPV | 1.051 (0.853, 1.296) | 0.639 | Â | Â |
RBC | 0.413 (0.162, 1.053) | 0.064 | Â | Â |
HGB | 0.971 (0.943, 1.000) | 0.053 | Â | Â |
NLR | 0.987 (0.927, 1.050) | 0.675 | Â | Â |
PLR | 1.001 (0.996, 1.006) | 0.591 | Â | Â |
MONO | 1.194(0.405,3.522) | 0.748 | Â | Â |
EOS | 0.684(0.126,3.715) | 0.660 | Â | Â |
BASO | 0.190(0.000,45866.481) | 0.793 | Â | Â |